A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Zoetis Inc. stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 370,845 shares of ZTS stock, worth $65.6 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares
370,845
Previous 526,898 29.62%
Holding current value
$65.6 Million
Previous $91.3 Million 20.68%
% of portfolio
0.38%
Previous 0.52%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$172.58 - $196.48 $26.9 Million - $30.7 Million
-156,053 Reduced 29.62%
370,845 $72.5 Million
Q2 2024

Aug 14, 2024

BUY
$145.54 - $178.83 $27.9 Million - $34.3 Million
191,810 Added 57.24%
526,898 $91.3 Million
Q1 2024

May 15, 2024

BUY
$165.67 - $199.94 $55.5 Million - $67 Million
335,088 New
335,088 $57.3 Billion
Q4 2023

Aug 14, 2024

SELL
$151.44 - $200.09 $2.66 Million - $3.52 Million
-17,577 Reduced 7.63%
212,754 $42 Billion
Q3 2023

Aug 14, 2024

BUY
$167.14 - $192.77 $13.7 Million - $15.8 Million
82,012 Added 55.29%
230,331 $40.1 Billion
Q2 2023

Aug 14, 2024

BUY
$160.94 - $186.23 $2.07 Million - $2.39 Million
12,838 Added 9.48%
148,319 $25.5 Billion
Q1 2023

Aug 14, 2024

BUY
$145.48 - $175.02 $8.09 Million - $9.74 Million
55,643 Added 69.69%
135,481 $22.5 Billion
Q4 2022

Aug 14, 2024

BUY
$131.14 - $157.47 $5.83 Million - $7 Million
44,464 Added 125.7%
79,838 $11.7 Billion
Q3 2022

Aug 14, 2024

BUY
$148.29 - $182.55 $39,296 - $48,375
265 Added 0.75%
35,374 $5.25 Billion
Q2 2022

Aug 14, 2024

BUY
$155.97 - $200.09 $122,592 - $157,270
786 Added 2.29%
35,109 $6.03 Billion
Q1 2022

Aug 14, 2024

SELL
$181.39 - $234.03 $89.3 Million - $115 Million
-492,575 Reduced 93.49%
34,323 $6.47 Billion
Q4 2021

Aug 30, 2024

SELL
$193.69 - $247.03 $264,967 - $337,937
-1,368 Reduced 3.96%
33,145 $8.08 Billion
Q3 2021

Aug 30, 2024

SELL
$189.29 - $209.69 $393,912 - $436,364
-2,081 Reduced 5.69%
34,513 $6.69 Billion
Q2 2021

Aug 30, 2024

SELL
$155.9 - $187.99 $76.4 Million - $92.2 Million
-490,304 Reduced 93.05%
36,594 $6.81 Billion
Q1 2021

Aug 30, 2024

BUY
$144.0 - $169.39 $3.17 Million - $3.72 Million
21,984 Added 143.71%
37,282 $5.87 Billion
Q4 2020

Aug 30, 2024

BUY
$157.07 - $174.35 $1.16 Million - $1.29 Million
7,401 Added 93.72%
15,298 $2.53 Billion
Q3 2020

Aug 30, 2024

SELL
$137.1 - $165.37 $61,009 - $73,589
-445 Reduced 5.33%
7,897 $1.31 Billion
Q2 2020

Aug 30, 2024

SELL
$111.92 - $142.53 $44,432 - $56,584
-397 Reduced 4.54%
8,342 $1.14 Billion
Q1 2020

Aug 30, 2024

BUY
$92.66 - $144.94 $34,284 - $53,627
370 Added 4.42%
8,739 $1.03 Billion
Q4 2019

Aug 30, 2024

SELL
$116.25 - $133.25 $1.16 Million - $1.33 Million
-9,969 Reduced 54.36%
8,369 $1.11 Billion
Q3 2019

Aug 30, 2024

SELL
$112.57 - $128.43 $111,669 - $127,402
-992 Reduced 5.13%
18,338 $2.28 Billion
Q2 2019

Aug 30, 2024

SELL
$97.98 - $114.28 $116,204 - $135,536
-1,186 Reduced 5.78%
19,330 $2.19 Billion
Q1 2019

Aug 30, 2024

BUY
$81.56 - $100.67 $195,091 - $240,802
2,392 Added 13.2%
20,516 $2.07 Billion
Q4 2018

Aug 30, 2024

SELL
$79.28 - $95.27 $40.3 Million - $48.5 Million
-508,774 Reduced 96.56%
18,124 $1.55 Billion
Q3 2018

Aug 30, 2024

SELL
$83.5 - $93.23 $74,148 - $82,788
-888 Reduced 4.51%
18,802 $1.72 Billion
Q2 2018

Aug 30, 2024

SELL
$79.9 - $89.2 $351,799 - $392,747
-4,403 Reduced 18.28%
19,690 $1.68 Billion
Q1 2018

Aug 30, 2024

BUY
$71.51 - $84.69 $131,578 - $155,829
1,840 Added 8.27%
24,093 $2.01 Billion
Q4 2017

Aug 30, 2024

SELL
$63.24 - $72.8 $12,015 - $13,832
-190 Reduced 0.85%
22,253 $1.6 Billion
Q3 2017

Aug 30, 2024

BUY
$59.73 - $65.4 $187,014 - $204,767
3,131 Added 16.21%
22,443 $1.43 Billion
Q1 2017

Aug 30, 2024

SELL
N/A
-507,586
19,312 $1.03 Billion

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.8B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.